Vireo Growth Inc. 8K

The company amended its Asset Purchase Agreement to restate and clarify the UCC Article 9 asset sale of PharmaCann-related Colorado cannabis dispensary assets and update related exhibits and noteholder directions as of May 8, 2026.

On May 8, 2026, Vireo Health, Inc., its parent Vireo Growth Inc., various Vireo acquisition entities, PharmaCann Inc., numerous PharmaCann-affiliated Colorado dispensary entities, and Argent Institutional Trust Company entered into a Second Amendment to their Asset Purchase Agreement, restating the recitals to clarify the structure of a UCC Article 9 private sale of encumbered and unencumbered assets tied to PharmaCann’s defaulted 12% Senior Secured Notes due 2025, updating the schedules of dispensaries and cannabis licenses (Exhibit A-1) and related terms (Exhibit C), and formally confirming that the collateral agent is acting at the direction of the required noteholders in connection with the contemplated disposition of the Colorado cannabis dispensary business assets.

Filing Facts

CIK

1771706

Ticker

-

Form

8K

Source Type

sec

Accession

0001104659-26-095427

Alert Tier

7